Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies - ResearchAndMarkets.com

businesswire.com
ATRC The article is a neutral company profile and product pipeline analysis report for AtriCure Inc, focusing on its medical technologies for atrial fibrillation treatment without providing explicit positive or negative outlooks on its stock performance.

DUBLIN--( BUSINESS WIRE)--The "AtriCure Inc (ATRC) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

AtriCure Inc (AtriCure) is a company specialising in the development and provision of medical technologies for the treatment of atrial fibrillation (Afib) and related conditions. The company's primary activities involve the development and distribution of medical devices used by electrophysiologists and cardiothoracic surgeons. AtriCure's major products include the Isolator Synergy ablation system, AtriClip left atrial appendage exclusion system, hybrid AF therapy, and cryoICE cryoSPHERE probe.

These products are used in various surgical procedures, including open-heart and minimally invasive surgeries, to treat Afib and manage post-operative pain. The company markets its products through various brands such as AtriCure, Coolrail, Isolator, Synergy, Flex-V, Lariat, Hybrid AF, cryosphere, cryoICE, AtriClip, COBRA, COBRA Fusion, Affirm, and EPi-Sense. It operates in the US, Germany, France, the UK, the Benelux region, Canada, and Australia, among other locations. AtriCure Inc is headquartered in Mason, Ohio, the US.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Reasons to Buy:

AtriCure Inc, Recent Developments

Key Topics Covered:

For more information about this company profile visit https://www.researchandmarkets.com/r/2idcyc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.